After finishing at $21.39 in the prior trading day, Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) closed at $20.33, down -4.96%. In other words, the price has decreased by -$1.06 from its previous closing price. On the day, 971384 shares were traded.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Ratios:
Our goal is to gain a better understanding of SNDX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.60 and its Current Ratio is at 18.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 09 when Morrison Briggs sold 52,855 shares for $21.41 per share. The transaction valued at 1,131,478 led to the insider holds 17,836 shares of the business.
Morrison Briggs sold 52,855 shares of SNDX for $1,032,237 on Apr 10. The Director now owns 17,836 shares after completing the transaction at $19.53 per share. On Mar 13, another insider, Morrison Briggs, who serves as the President, Head of R&D of the company, sold 52,854 shares for $22.53 each. As a result, the insider received 1,190,674 and left with 17,836 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1.40B and an Enterprise Value of 912.02M. Its current Enterprise Value per Revenue stands at 7.85 whereas that against EBITDA is -6.05.
Stock Price History:
Over the past 52 weeks, SNDX has reached a high of $29.86, while it has fallen to a 52-week low of $13.88. The 50-Day Moving Average of the stock is 20.98, while the 200-Day Moving Average is calculated to be 23.41.
Shares Statistics:
The stock has traded on average 893.08K shares per day over the past 3-months and 964.14k shares per day over the last 10 days, according to various share statistics. A total of 69.44M shares are outstanding, with a floating share count of 57.43M. Insiders hold about 0.30% of the company’s shares, while institutions hold 90.20% stake in the company. Shares short for SNDX as of Apr 27, 2023 were 6.52M with a Short Ratio of 6.39M, compared to 7.63M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 9.53% and a Short% of Float of 12.47%.
Earnings Estimates
Its stock is currently analyzed by 7 different market analysts. On average, analysts expect EPS of -$0.73 for the current quarter, with a high estimate of -$0.7 and a low estimate of -$0.81, while EPS last year was -$0.62. The consensus estimate for the next quarter is -$0.83, with high estimates of -$0.7 and low estimates of -$0.91.
Analysts are recommending an EPS of between -$2.32 and -$3.35 for the fiscal current year, implying an average EPS of -$3.06. EPS for the following year is -$3.01, with 9 analysts recommending between -$2.23 and -$3.96.
Revenue Estimates
Based on 9 analysts’ estimates, the company’s revenue will be $53.33M in the next fiscal year. The high estimate is $123.62M and the low estimate is $11.59M. The average revenue growth estimate for next year is up 442.50% from the average revenue estimate for this year.
